GGrantIndex
← Leaderboards

Michael A Rubin

University Of Utah

$1,644,585
Attributed
$3,016,607
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $806.8K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

CDC$2,744,044 · 1
AHRQ$269,460 · 1
NIH$3,103 · 2
VA$0 · 5

By mechanism

U54$2,744,044 · 1
K08$269,460 · 1
P41$3,103 · 2
I01$0 · 3
I50$0 · 1
IP1$0 · 1

Top collaborators

Most similar at University Of Utah

Same institution · by research overlap

Others in their field

Top investigators on “Infection Control

Research focus

Infection ControlPoliciesFutureVeteransInfectionTransmission ProcessEpidemiologyHospitalsCostServicesPathogenSeriesPreventionPreventProgramsInfection PreventionProviderEnvironmentBehaviorBaseComputer SimulationCommunicable DiseasesEpidemiologic MethodsAffect

Grant awards (27)

Intermountain Program on Antibiotic Resistance and microbial Threats (IMPART)$599,993
U54 · FY2025 · CK
Intermountain Program on Antibiotic Resistance and microbial Threats (IMPART)$599,996
U54 · FY2024 · CK
Intermountain Program on Antibiotic Resistance and microbial Threats (IMPART)$737,241
U54 · FY2023 · CK
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)$0
IP1 · FY2021 · VA · contact PI
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)$0
I50 · FY2021 · VA · contact PI
Intermountain Program on Antibiotic Resistance and microbial Threats (IMPART)$546,000
U54 · FY2020 · CK
Intermountain Program on Antibiotic Resistance and microbial Threats (IMPART)$260,814
U54 · FY2020 · CK
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)$0
IP1 · FY2020 · VA · contact PI
Preventing MRSA infections: a virtual comparative effectiveness model$0
I01 · FY2020 · VA · contact PI
Preventing MRSA infections: a virtual comparative effectiveness model$0
I01 · FY2019 · VA · contact PI
Preventing MRSA infections: a virtual comparative effectiveness model$0
I01 · FY2018 · VA · contact PI
Preventing MRSA infections: a virtual comparative effectiveness model$0
I01 · FY2018 · VA · contact PI
Preventing MRSA infections: a virtual comparative effectiveness model$0
I01 · FY2018 · VA · contact PI
Preventing MRSA infections: a virtual comparative effectiveness model$0
I01 · FY2015 · VA · contact PI
Antimicrobial Use and Control of Clostridium difficile transmission and infection$0
I01 · FY2013 · VA · contact PI
Improving MRSA control through simulation and surveillance$0
I01 · FY2013 · VA · contact PI
Antimicrobial Use and Control of Clostridium difficile transmission and infection$0
I01 · FY2012 · VA · contact PI
Improving MRSA control through simulation and surveillance$0
I01 · FY2011 · VA · contact PI
Improving MRSA control through simulation and surveillance$0
I01 · FY2009 · VA · contact PI
Antibiotic use and bacteriuria in the rural nursing home$134,730
K08 · FY2007 · HS · contact PI
Antibiotic use and bacteriuria in the rural nursing home$134,730
K08 · FY2006 · HS · contact PI
UNDERGRADUATE RESEARCH IN BIOINFORMATICS AT UPR-CAYEY CAMPUS$1,012
P41 · FY2006 · RR · contact PI
UNDERGRADUATE RESEARCH IN BIOINFORMATICS AT UPR-CAYEY CAMPUS$1,028
P41 · FY2005 · RR
Antibiotic use and bacteriuria in the rural nursing home$0
K08 · FY2005 · HS
Undergraduate Research in Bioinformatics at UPR-Cayey Campus$1,063
P41 · FY2004 · RR
Antibiotic use and bacteriuria in the rural nursing home$0
K08 · FY2004 · HS
Antibiotic use and bacteriuria in the rural nursing home$0
K08 · FY2003 · HS